Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioThema is a Swedish life science tools company that develops and sells reagents, kits, assays, and luminometers based on the firefly luciferase reaction. Its products are used to measure ATP and ATP-coupled biological activity in applications including cell viability, cell counting, cytotoxicity, kinase and metabolite assays, reporter gene assays, immunoassays, bacterial quantification, and hygiene monitoring. The company also provides custom assay development and OEM manufacturing for ATP reagent lines. BioThema appears to operate as a small private commercial company rather than a therapeutic drug developer, serving research, pharma, biotech, healthcare, and industrial customers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioThema.